PSORIASIS

HealthValue.

Four key therapeutic breakthroughs thanks to monoclonals and fusion proteins

An anti CD11a  (cell adhesion factor) monoclonal antibody : efalizumab

A fusion protein between the extra cellular  portion of LFA3, and the Fc domain of a human IgG1 : alefacept

Back to home page

Anti TNF drugs :

- an anti TNF monoclonal antibody : infliximab

- an anti TNF fusion protein : etanercept

PSORIASIS

Psoriasis main page

Psoriasis mechanism

Alefacept

Efalizumab

Etanercept, anti TNF

Infliximab, anti TNF

Certolizumab

changer de langue